BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian germ cell tumor AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Prognosis
224 results:

  • 1. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
    Bao ML; Li X; Chen G; Li H; Chen W; Li HX
    Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 3. [A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment].
    Yao Y; Liu J; Zhou X; Liu Z; Qiu S; He Y; Zhou X
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):70-82. PubMed ID: 38293978
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.
    Vasanth A; Patel SM; Arora R; Parekh CD; Dave P; Patel BM; Vemanamandhi P
    J Gynecol Oncol; 2024 Mar; 35(2):e19. PubMed ID: 37921603
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
    Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
    Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers.
    Oubaddou Y; Ben Ali F; Oubaqui FE; Qmichou Z; Bakri Y; Ameziane El Hassani R
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3139-3153. PubMed ID: 37774066
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of pediatric oncologist in prenatal diagnosis: A 10-year retrospective study at Assistance Publique Hôpitaux de Marseille (AP-HM).
    Min V; Coze S; D'Ercole C; Panait N; Sigaudy S; Aschero A; Zattara H; Bretelle F; Revon-Riviere G; Coze C
    Pediatr Hematol Oncol; 2024; 41(1):30-40. PubMed ID: 37599628
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recurrent squamous cell carcinoma arising in ovary mature cystic teratoma: A case report.
    Ji X; Zhai P; Yang H; Wang H; Wang X
    Medicine (Baltimore); 2023 Aug; 102(32):e34734. PubMed ID: 37565860
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A 10-year clinicopathological analysis of ovarian lesions in a tertiary hospital in Southern Nigeria.
    Abasiattai AM; Nwafor CC; Utuk NM
    Afr Health Sci; 2023 Mar; 23(1):459-468. PubMed ID: 37545925
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impacts of ovarian preservation on the prognosis of neuroendocrine cervical carcinoma: a retrospective analysis based on machine learning.
    Xiang X; Zhang Y; Hua K; Ding J
    World J Surg Oncol; 2023 May; 21(1):146. PubMed ID: 37173713
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
    Chu R; Liu P; Chen J; Cheng X; Li K; Che Y; Wang J; Li L; Zhang X; Yao S; Song L; Zhao Y; Huang C; Xue Y; Pan X; Li J; Chen Z; Jiang J; Kong B; Song K
    J Gynecol Oncol; 2023 Mar; 34(2):e12. PubMed ID: 36890292
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Assessment of prognostic and reproductive outcomes of omentectomy for patients with clinically apparent early-stage (I, II) malignant ovarian germ cell tumours: A multicentre retrospective study.
    Liu P; Li Z; Cheng X; Gao Q; Che Y; Zhang Z; Chu R; Chen Z; Zhang Y; Wang Q; Dou Z; Wei Y; Cui Z; Wang J; Xie X; Ma D; Yang X; Kong B; Song K
    BJOG; 2022 Nov; 129 Suppl 2():23-31. PubMed ID: 36485067
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
    Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
    Front Immunol; 2022; 13():918254. PubMed ID: 36466914
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid.
    Li S; Wang X; Sui X; Zhang X; Yin M; Yang J
    BMC Cancer; 2022 Oct; 22(1):1090. PubMed ID: 36280824
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Squamous cell carcinoma in mature cystic teratoma of the ovary induced by human papillomavirus 16 infection: A case report and literature review.
    Shi Z; Yang L; Bian C
    Medicine (Baltimore); 2022 Sep; 101(38):e30667. PubMed ID: 36197169
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinicopathological features, prognosis, and fertility outcomes in Chinese Han women treated for ovarian yolk sac tumor: A retrospective case series study from two tertiary-care academic medical centers.
    Qin L; Wang B; Wang Z; He D
    Medicine (Baltimore); 2022 Jul; 101(29):e29868. PubMed ID: 35866762
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Fast-growing immature ovarian teratoma during pregnancy: a case report and a review of the literature.
    He Z; Lu Y; Xie C
    BMC Pregnancy Childbirth; 2022 Jun; 22(1):519. PubMed ID: 35761185
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Anti-NMDA Receptor Encephalitis: Retrospective Analysis of 15 Cases, Literature Review, and Implications for Gynecologists.
    Liu Y; Tian Y; Guo R; Xu X; Zhang M; Li Z; Xiao Y; Cao W; Gao H; Kong D; Du Y; Meng L; Zhang J; Huang X
    J Healthc Eng; 2022; 2022():4299791. PubMed ID: 35340259
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature.
    Matsumoto NP; Yuan J; Wang J; Shen Q; Chen X; Kim Y; Zuppan CW; Chang CC; Cui W; Chen D; Shi M; Gisriel SD; Chen M; Xu ML; Pan Z
    Mod Pathol; 2022 Jul; 35(7):865-874. PubMed ID: 35105959
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.